Advanz Pharma will leverage its specialty, hospital, and rare disease expertise and infrastructure to commercialize AT-007 in Europe for both Galactosemia and SORD Deficiency
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
Wegovy is now offered in six weekly doses in the EU: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg, and the newly approved 7.2 mg dose
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
The partnership initially will focus on cardiovascular and kidney diseases
CARsgen is working to transform outcomes for patients with solid tumors by advancing the potential of CAR T technologies
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Subscribe To Our Newsletter & Stay Updated
